Curasight A/S (NGM:CURAS)
Sweden · Delayed Price · Currency is SEK · Price in DKK 3.420
+0.220 (6.87%)
At close: Aug 8, 2025
Achilles Therapeutics Market Cap
Curasight has a market cap or net worth of 234.58 million as of August 8, 2025. Its market cap has decreased by -38.06% in one year.
Market Cap
234.58M
Enterprise Value
249.15M
Revenue
n/a
Ranking
n/a
PE Ratio
n/a
Stock Price
$3.42
Market Cap Chart
Since October 8, 2020, Curasight's market cap has decreased from 487.08M to 234.58M, a decrease of -51.84%. That is a compound annual growth rate of -14.03%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Aug 7, 2025 | 219.56M | -21.10% |
| Dec 30, 2024 | 278.27M | -47.31% |
| Dec 29, 2023 | 528.14M | 74.12% |
| Dec 30, 2022 | 303.32M | -60.33% |
| Dec 30, 2021 | 764.60M | 22.43% |
| Dec 30, 2020 | 624.53M | 28.22% |
| Oct 8, 2020 | 487.08M | - |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Investor AB | 868.57B |
| Atlas Copco AB | 685.15B |
| AB Volvo | 554.88B |
| EQT AB | 391.48B |
| ASSA ABLOY AB | 357.34B |
| Skandinaviska Enskilda Banken AB | 341.17B |
| Swedbank AB | 296.01B |
| Sandvik AB | 295.16B |